4//SEC Filing
Orenstein Daniel H. 4
Accession 0001562180-21-007531
CIK 0001636422other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:14 PM ET
Size
15.1 KB
Accession
0001562180-21-007531
Insider Transaction Report
Form 4
Orenstein Daniel H.
General Counsel
Transactions
- Sale
Common Stock
2021-12-06$37.53/sh−1,100$41,288→ 70,329 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-03−2,500→ 118,500 totalExercise: $10.34Exp: 2026-02-10→ Common Stock (2,500 underlying) - Tax Payment
Common Stock
2021-12-02$41.95/sh−4,117$172,698→ 71,429 total - Sale
Common Stock
2021-12-03$42.87/sh−2,500$107,175→ 71,429 total - Sale
Common Stock
2021-12-06$38.60/sh−3,533$136,384→ 66,796 total - Exercise/Conversion
Common Stock
2021-12-03$10.34/sh+2,500$25,850→ 73,929 total
Footnotes (6)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
- [F3]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
- [F4]Represents the weighted average sale price of the shares sold ranging from $37.35 to $37.69 per share, inclusive.
- [F5]Represents the weighted average sale price of the shares sold ranging from $38.35 to $39.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (5).
- [F6]25% of the 136,316 shares underlying the options vested in an annual installment on December 31, 2016 and the remaining balance vested in equal monthly installments until the option vested in full on Dec. 31, 2019.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001494174
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:14 PM ET
- Size
- 15.1 KB